MiR-181a enhances drug sensitivity in mitoxantone-resistant breast cancer cells by targeting breast cancer resistance protein (BCRP/ABCG2).
about
The effects of microRNA on the absorption, distribution, metabolism and excretion of drugsMiRNAs and miRNA Polymorphisms Modify Drug ResponseVitamin C effect on mitoxantrone-induced cytotoxicity in human breast cancer cell linesThe multiple facets of drug resistance: one history, different approaches.Hsa-microRNA-181a is a regulator of a number of cancer genes and a biomarker for endometrial carcinoma in patients: a bioinformatic and clinical study and the therapeutic implication.Induction of miRNA-181a by genotoxic treatments promotes chemotherapeutic resistance and metastasis in breast cancer.MicroRNA Pharmacoepigenetics: Posttranscriptional Regulation Mechanisms behind Variable Drug Disposition and Strategy to Develop More Effective TherapyMaitake Pro4X has anti-cancer activity and prevents oncogenesis in BALBc mice.Regulation of multidrug resistance by microRNAs in anti-cancer therapyMultidrug-resistant breast cancer: current perspectives.Targeting the RAS/MAPK pathway with miR-181a in acute myeloid leukemia.MicroRNA: a prognostic biomarker and a possible druggable target for circumventing multidrug resistance in cancer chemotherapyStructure and function of BCRP, a broad specificity transporter of xenobiotics and endobiotics.The role of microRNAs in human breast cancer progression.Vectors and strategies for nonviral cancer gene therapy.MicroRNA-181a promotes docetaxel resistance in prostate cancer cells.MicroRNAs and Cancer Drug Resistance.Chicken gga-miR-181a targets MYBL1 and shows an inhibitory effect on proliferation of Marek's disease virus-transformed lymphoid cell line.MicroRNA Profile in Response to Doxorubicin Treatment in Breast Cancer.Involvement of miR-133a and miR-326 in ADM resistance of HepG2 through modulating expression of ABCC1.ATP-binding cassette transmembrane transporters and their epigenetic control in cancer: an overview.Epigenetic regulation of drug transporter expression in human tissues.Autophagy and multidrug resistance in cancer.The miR-181 family promotes cell cycle by targeting CTDSPL, a phosphatase-like tumor suppressor in uveal melanoma.Screen for MicroRNA and Drug Interactions in Breast Cancer Cell Lines Points to miR-126 as a Modulator of CDK4/6 and PIK3CA Inhibitors.Functional role of ginseng-derived compounds in cancer.
P2860
Q26822987-64B5B8E7-3E29-408C-AEF6-3BA5FF408EC4Q28079075-240BC6A2-9627-4E08-AFEB-86294B0C5F6CQ28542814-5157FA54-9FC4-42D8-9F1F-0A921C978128Q33697116-4982DAD3-B540-4EC1-A72D-198FC9D94516Q35125641-153B7642-088E-456A-AD60-463F5CE2E0EDQ36338901-5D339CB9-FF87-4A05-861F-12132AA24D2AQ36618667-C98740B5-698B-400E-A29F-EC6CA0793F9BQ37321080-5FA7B6DD-E245-4000-AB06-B7D549741CA8Q37587311-E9FED020-6E84-4334-A1EB-6E05A28CCDB4Q37593383-094F200B-7013-4009-BEBF-6965F046265EQ37644854-562B70D7-4C8B-4C36-AC31-C16C41EDC610Q38172970-F9C7A021-36D0-4AB8-B1F0-AB19B392232DQ38207943-7AEA9D05-EC27-4FCD-A19D-B9B4FBDA7754Q38221040-E29C764B-F3DE-4705-ABAD-8A589E14E26BQ38694798-B90D5667-E255-4B5D-A100-BD82444A04B5Q38704252-2AA96340-85E3-46C1-A4C9-EC33AE9DE719Q38748118-4212E2A5-F8ED-4BE3-8F55-3A63DAC64130Q38824967-80E1EAD6-1595-489B-A7A2-6BF34714932EQ38895915-5764EEF9-58B2-4B40-9AA7-EAA10D0A494EQ38906160-98534226-6D37-4D70-AD2C-85CC42389BB6Q38908841-3A2E1A26-B2DD-49D1-B35F-03B1588A3E30Q38942246-D7FB3593-7D6B-4783-A3FA-060C2DD33767Q39395779-5793E5DE-FEEB-41B7-8252-F2480C2EDBC0Q49305692-A457791B-40A4-4DD7-966A-7E8474CA12B7Q55026357-485E363A-DC7C-4D87-870C-0AD59F46D739Q55494410-4F56249C-4696-45F5-AE0B-BA3A8D061437
P2860
MiR-181a enhances drug sensitivity in mitoxantone-resistant breast cancer cells by targeting breast cancer resistance protein (BCRP/ABCG2).
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
MiR-181a enhances drug sensiti ...... sistance protein (BCRP/ABCG2).
@en
MiR-181a enhances drug sensiti ...... east cancer resistance protein
@nl
type
label
MiR-181a enhances drug sensiti ...... sistance protein (BCRP/ABCG2).
@en
MiR-181a enhances drug sensiti ...... east cancer resistance protein
@nl
prefLabel
MiR-181a enhances drug sensiti ...... sistance protein (BCRP/ABCG2).
@en
MiR-181a enhances drug sensiti ...... east cancer resistance protein
@nl
P2093
P2860
P1476
MiR-181a enhances drug sensiti ...... sistance protein (BCRP/ABCG2).
@en
P2093
Enhua Wang
Mengtao Ma
Mingyi Zhou
Minjie Wei
Qiuchen Chen
Xinnan Zhao
Xuefeng Bai
Xuyang Jiao
P2860
P2888
P304
P356
10.1007/S10549-013-2607-X
P407
P577
2013-06-19T00:00:00Z